Mark I Sheiman

Title: Mark I Sheiman: Innovator in Immunoassay Technology

Introduction

Mark I Sheiman is a notable inventor based in Nanuet, NY (US). He has made significant contributions to the field of immunoassay technology, particularly through his innovative patent. His work has implications for medical diagnostics and therapeutic monitoring.

Latest Patents

Mark I Sheiman holds a patent for an "Agglutination immunoassay for hapten involving monoclonal antibody." This assay method and kit are designed for detecting haptens such as theophylline. The invention utilizes a first latex reagent and a second antibody reagent. By employing a monoclonal antibody of the IgA class in the second reagent, the method effectively prevents interference from patient rheumatoid factor. This advancement enhances the accuracy and reliability of immunoassays.

Career Highlights

Mark I Sheiman is associated with Fisher Scientific Company, where he has contributed to various projects and innovations. His expertise in immunoassay technology has positioned him as a valuable asset in the field. With a focus on improving diagnostic methods, he continues to influence the industry positively.

Collaborations

Mark has worked alongside talented colleagues, including Kwok K Yeung and Teresa H Chan. Their collaborative efforts have furthered advancements in immunoassay technology and contributed to the success of their projects.

Conclusion

Mark I Sheiman's contributions to immunoassay technology exemplify the impact of innovation in medical diagnostics. His patent and work at Fisher Scientific Company highlight his commitment to enhancing healthcare solutions.